The refinancing extends maturities and removes near-term refinancing risk. Monitor next quarterly earnings for leverage ratio and covenant headroom, especially if revolver usage exceeds 40% of the facility. No immediate trading catalyst.
Price Chart
Executive Summary
Lumexa Imaging entered into Amendment No. 7 to its credit agreement, refinancing its existing $823M secured term loan and maintaining a $250M revolving credit facility. The transaction extends maturities to 2032 (term loan) and 2030 (revolver) with interest at SOFR+2.50% or Prime+1.50%. This is a routine liability management event that removes near-term maturity risk but does not change the company's total debt or fundamental outlook.
Key Financial Metrics
Key Facts
- Secured term loan facility of approximately $823 million (Amendment No. 7 Replacement Term Loans) to repay existing Amendment No. 5 term loans.
- Secured revolving credit facility of $250 million maintained.
- Term loan matures December 2032; revolving facility matures December 2030.
- Interest rate: SOFR + 2.50% or Prime Rate + 1.50% (revolver rate subject to step-downs based on leverage).
- Financial covenant triggers if revolving exposure exceeds 40% of the facility: consolidated net leverage ratio ≤ 7.50x.
- Proceeds used solely to refinance existing debt and pay fees; no new cash raised.
Financial Impact
Refinancing of $823M term loan and $250M revolver; no change in total debt outstanding. Interest rate unchanged at SOFR+2.50%.
Risk Factors
- High absolute leverage (~$1.07B total facilities vs $1.1B market cap) leaves limited covenant cushion.
- Financial covenant (7.50x net leverage) could be binding if EBITDA declines or revolver draws increase.
- Variable-rate exposure (SOFR+2.50%) creates earnings sensitivity to rising interest rates.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-290788 |
| Document: d155301d8k.htm | 0001193125-26-290788 |
| Document: 0001193125-26-290788-index-headers.html | 0001193125-26-290788 |
| Document: 0001193125-26-290788-index.html | 0001193125-26-290788 |
| Document: 0001193125-26-290788.txt | 0001193125-26-290788 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 10w ago | 8-K | $12.20 | awaiting T+60 | — | $11.67 (−4.34%) |
Jun 30, 2026 17w ago | 8-K | $11.59 $9.88 | ▼ −14.75% | ▼ −17.63% | $11.67 (+0.69%) |
May 12, 2026 24w ago | 8-K | $8.05 $11.58 | ▲ +43.85% | ▲ +39.41% | $11.67 (+44.97%) |
May 12, 2026 24w ago | Press Release | $8.05 $11.58 | ▼ −43.85% | ▼ −39.41% | $11.67 (−44.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers